Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study

A Sharma, NS Bhatt, A St Martin, MB Abid… - The Lancet …, 2021 - thelancet.com
Background Haematopoietic stem-cell transplantation (HSCT) recipients are considered at
high risk of poor outcomes after COVID-19 on the basis of their immunosuppressed status …
被引用次数：350 相关文章
[HTML] nih.gov

[HTML][HTML] Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study

A Sharma, NS Bhatt, A St Martin, MB Abid… - The Lancet …, 2021 - ncbi.nlm.nih.gov
Background Haematopoietic stem-cell transplantation (HSCT) recipients are considered at
high risk of poor outcomes after COVID-19 on the basis of their immunosuppressed status …
[HTML] thelancet.com

[HTML][HTML] Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study

A Sharma, NS Bhatt, A St Martin, MB Abid… - The Lancet …, 2021 - thelancet.com
Background Haematopoietic stem-cell transplantation (HSCT) recipients are considered at
high risk of poor outcomes after COVID-19 on the basis of their immunosuppressed status …

Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study

A Sharma, NS Bhatt, A St Martin… - The Lancet …, 2021 - mdanderson.elsevierpure.com
Background: Haematopoietic stem-cell transplantation (HSCT) recipients are considered at
high risk of poor outcomes after COVID-19 on the basis of their immunosuppressed status …

Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study

A Sharma, NS Bhatt, A St Martin, MB Abid… - The Lancet …, 2021 - Elsevier
Background Haematopoietic stem-cell transplantation (HSCT) recipients are considered at
high risk of poor outcomes after COVID-19 on the basis of their immunosuppressed status …

[引用][C] Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study

A Sharma, NS Bhatt, A St Martin, MB Abid… - The Lancet …, 2021 - cir.nii.ac.jp
Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation
recipients: an observational cohort study | CiNii Research CiNii 国立情報学研究所 学術情報 …

Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study.

A Sharma, NS Bhatt, A St Martin, MB Abid… - The Lancet …, 2021 - europepmc.org
Background Haematopoietic stem-cell transplantation (HSCT) recipients are considered at
high risk of poor outcomes after COVID-19 on the basis of their immunosuppressed status …

Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study

A Sharma, NS Bhatt, A St Martin… - The Lancet …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Haematopoietic stem-cell transplantation (HSCT) recipients are considered at
high risk of poor outcomes after COVID-19 on the basis of their immunosuppressed status …

Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study.

A Sharma, NS Bhatt, A St Martin, MB Abid… - The Lancet …, 2021 - europepmc.org
Background Haematopoietic stem-cell transplantation (HSCT) recipients are considered at
high risk of poor outcomes after COVID-19 on the basis of their immunosuppressed status …